We are a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases with significant unmet needs. We have built our product pipeline through the strategic acquisition of privately-held companies with clinical-stage assets and we currently are focused on developing new therapies for sickle cell disease, a chronic, genetic disorder classified as a rare, or orphan, disease in the United States and European Union, and for heart failure, a condition with a high unmet need for innovative treatment options.

Employee Rating

0More
TypePublic
HQSan Diego, US
Founded1995
Size (employees)14 (est)+134%
Websitemasttherapeutics.com
Mast Therapeutics was founded in 1995 and is headquartered in San Diego, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Mast Therapeutics Office Locations

Mast Therapeutics has an office in San Diego
San Diego, (HQ)
500 3611 Valley Centre Dr
Show all (1)
Report incorrect company information

Mast Therapeutics Financials and Metrics

Mast Therapeutics Revenue

Mast Therapeutics's revenue was reported to be $128 k in FY, 2016
USD

Net income (Q3, 2018)

(12.6m)

EBIT (Q3, 2018)

(12.8m)

Market capitalization (31-Aug-2018)

358.7m

Cash (30-Sep-2018)

24.9m
Mast Therapeutics's current market capitalization is $358.7 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

128.0k

Revenue growth, %

(100%)

General and administrative expense

11.0m9.3m11.1m

R&D expense

12.9m19.4m28.3m20.8m18.5m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

45.0k94.0k

General and administrative expense

2.2m2.3m2.4m2.5m3.6m2.4m2.5m2.8m2.4m2.1m1.6m5.1m1.5m1.8m2.5m3.1m

R&D expense

3.1m4.3m4.8m5.4m6.0m7.7m7.3m7.9m7.8m5.1m1.4m4.2m5.0m8.5m9.3m9.5m

Operating expense total

5.3m6.8m7.2m7.9m9.7m10.2m9.8m10.7m10.2m7.2m5.8m9.3m6.5m32.1m11.9m12.8m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

25.7m35.8m23.1m8.5m22.1m

Inventories

1.1m1.1m1.3m903.0k

Current Assets

45.5m58.4m42.3m12.2m97.9m

PP&E

105.7k188.0k226.0k99.0k925.0k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(21.5m)(28.7m)(39.8m)(36.1m)(29.8m)

Depreciation and Amortization

39.5k85.0k146.0k99.0k363.0k

Accounts Payable

2.5m1.2m159.0k

Cash From Operating Activities

(17.8m)(24.6m)(32.9m)(37.3m)(28.2m)
Quarterly
USDY, 2018

Financial Leverage

1.3 x
Show all financial metrics
Report incorrect company information

Mast Therapeutics Online and Social Media Presence

Embed Graph
Report incorrect company information

Mast Therapeutics Company Life and Culture

Report incorrect company information

Mast Therapeutics Frequently Asked Questions

  • When was Mast Therapeutics founded?

    Mast Therapeutics was founded in 1995.

  • How many employees does Mast Therapeutics have?

    Mast Therapeutics has 14 employees.

  • Who are Mast Therapeutics competitors?

    Competitors of Mast Therapeutics include Sucampo Pharmaceuticals, Array BioPharma and Amarin.

  • Where is Mast Therapeutics headquarters?

    Mast Therapeutics headquarters is located at 500 3611 Valley Centre Dr, San Diego.

  • Where are Mast Therapeutics offices?

    Mast Therapeutics has an office in San Diego.

  • How many offices does Mast Therapeutics have?

    Mast Therapeutics has 1 office.